These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 21900086)

  • 1. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
    Montgomery RL; Hullinger TG; Semus HM; Dickinson BA; Seto AG; Lynch JM; Stack C; Latimer PA; Olson EN; van Rooij E
    Circulation; 2011 Oct; 124(14):1537-47. PubMed ID: 21900086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
    Dickinson BA; Semus HM; Montgomery RL; Stack C; Latimer PA; Lewton SM; Lynch JM; Hullinger TG; Seto AG; van Rooij E
    Eur J Heart Fail; 2013 Jun; 15(6):650-9. PubMed ID: 23388090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
    Callis TE; Pandya K; Seok HY; Tang RH; Tatsuguchi M; Huang ZP; Chen JF; Deng Z; Gunn B; Shumate J; Willis MS; Selzman CH; Wang DZ
    J Clin Invest; 2009 Sep; 119(9):2772-86. PubMed ID: 19726871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of miR-208a in the heart.
    Oliveira-Carvalho V; Carvalho VO; Bocchi EA
    DNA Cell Biol; 2013 Jan; 32(1):8-12. PubMed ID: 23121236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-208a as a biomarker of isoproterenol-induced cardiac injury in Sod2+/- and C57BL/6J wild-type mice.
    Liu L; Aguirre SA; Evering WE; Hirakawa BP; May JR; Palacio K; Wang J; Zhang Y; Stevens GJ
    Toxicol Pathol; 2014 Oct; 42(7):1117-29. PubMed ID: 24713317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-208a in Cardiac Hypertrophy and Remodeling.
    Huang XH; Li JL; Li XY; Wang SX; Jiao ZH; Li SQ; Liu J; Ding J
    Front Cardiovasc Med; 2021; 8():773314. PubMed ID: 34957257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.
    Tony H; Yu K; Qiutang Z
    Oxid Med Cell Longev; 2015; 2015():597032. PubMed ID: 26137188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.
    Azibani F; Devaux Y; Coutance G; Schlossarek S; Polidano E; Fazal L; Merval R; Carrier L; Solal AC; Chatziantoniou C; Launay JM; Samuel JL; Delcayre C
    PLoS One; 2012; 7(5):e38197. PubMed ID: 22666483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
    Ben-Nun D; Buja LM; Fuentes F
    Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Cardiac Anti-miR-208a Therapy Is Stress Dependent.
    Eding JE; Demkes CJ; Lynch JM; Seto AG; Montgomery RL; Semus HM; Jackson AL; Isabelle M; Chimenti S; van Rooij E
    Mol Ther; 2017 Mar; 25(3):694-704. PubMed ID: 28202391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart.
    Wang BW; Wu GJ; Cheng WP; Shyu KG
    PLoS One; 2014; 9(1):e84188. PubMed ID: 24392114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
    Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
    Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly.
    Ai J; Zhang R; Gao X; Niu HF; Wang N; Xu Y; Li Y; Ma N; Sun LH; Pan ZW; Li WM; Yang BF
    Cardiovasc Res; 2012 Aug; 95(3):385-93. PubMed ID: 22719074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.
    Diniz GP; Takano AP; Barreto-Chaves ML
    Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
    Martinez EC; Lilyanna S; Wang P; Vardy LA; Jiang X; Armugam A; Jeyaseelan K; Richards AM
    J Mol Cell Cardiol; 2017 Nov; 112():27-39. PubMed ID: 28865712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction.
    Shyu KG; Wang BW; Cheng WP; Lo HM
    Can J Cardiol; 2015 May; 31(5):679-90. PubMed ID: 25936493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.